Evidence map›Paper›PMID 18619982›Full record

ArticleNeuropharmacology2008

Dual neurotoxic and neuroprotective role of metabotropic glutamate receptor 1 in conditions of trophic deprivation - possible role as a dependence receptor.

Sergey Pshenichkin, Monika Dolińska, Małgorzata Klauzińska, Victoria Luchenko, Ewa Grajkowska, Jarda T Wroblewski

Abstract read
In one paragraph

Article in Neuropharmacology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 31 citations in OpenAlex.

  1. Early Effects of the Soluble Amyloid βInternational journal of molecular sciences · 2021
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Glutamate, glutamate receptors, and downstream signaling pathways.International journal of biological sciences · 2013
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sergey PshenichkinDepartment of Pharmacology, Georgetown University Medical Center, 3900 Reservoir Road NW, Washington, DC 20057, United States.
Monika Dolińska
Małgorzata Klauzińska
Victoria Luchenko
Ewa Grajkowska
Jarda T Wroblewski
Georgetown University · USGeorgetown University Medical Center · US

Funding

METABOTROPIC GLUTAMATE RECEPTORS IN NEUROTOXICITYR01NS037436 · NINDS · GEORGETOWN UNIVERSITY · PI WROBLEWSKI, JARDA T · 2000 to 2011
$2.5M
NINDS NIH HHS NS37436NINDS NIH HHS R01 NS037436
6 · The paper itself

Abstract

Group I metabotropic glutamate receptors have been often implicated in various models of neuronal toxicity, however, the role played by the individual receptors and their putative mechanisms of action contributing to neurotoxicity or neuroprotection remain unclear. Here, using primary cultures of rat cerebellar granule cells and mouse cortical neurons, we show that conditions of trophic deprivation increased mGlu1 expression which correlated with the developing cell death. The inhibition of mGlu1 expression by specific siRNA attenuated toxicity, while adenovirus-mediated overexpression of mGlu1 resulted in increased cell death, indicating a causal relationship between the level of receptor expression and neuronal survival. In pharmacological experiments selective mGlu1 antagonists failed to protect from mGlu1-induced cell death, instead, neuronal survival was promoted by glutamate acting at mGlu1 receptors. Such properties are characteristics of a novel heterogeneous family of dependence receptors which control neuronal apoptosis. Our findings indicate that increased expression of mGlu1 in neurons creates a state of cellular dependence on the presence of its endogenous agonist glutamate. We propose a new role and a new mechanism for mGlu1 action. This receptor may play a crucial role in determining the fate of individual neurons during the development of the nervous system.

Indexed as

AnimalsCells, CulturedCell SurvivalCerebellumCerebral CortexChromonesDioxolanesExcitatory Amino Acid AgonistsExcitatory Amino Acid AntagonistsGene ExpressionGlutamic AcidGreen Fluorescent ProteinsIntercellular Signaling Peptides and ProteinsMiceNeuronsPotassium Chloride4-(2-amino-6-chloro-9H-purin-9-yl)-1,3-dioxolane-2-methanol6-methyl-2-(phenylethynyl)pyridine7-(hydroxyimino)cyclopropan(b)chromen-1a-carbxoylic acid ethyl esterChromonesDioxolanesExcitatory Amino Acid AgonistsExcitatory Amino Acid AntagonistsGlutamic AcidGreen Fluorescent ProteinsIntercellular Signaling Peptides and Proteinsmetabotropic glutamate receptor type 1Potassium ChloridePurinesPyridinesReceptors, Metabotropic GlutamateRNA, Small Interfering

Identifiers

PMID18619982
PMCPMC2606294
OpenAlexW2087141223

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.